Aptose Biosciences, Inc. (NASDAQ:APTO) management will conduct a conference call for 4th August 2020 at 5:00 PM Eastern Time to discuss financial results and companys performance for 2Q20.
The conference call will also be available live on the website www.aptose.com
Earnings Expectation
Aptose Biosciences, Inc. a clinical-stage biotechnology company, is expected to report second quarter earnings results, after market close, on Tuesday 4th August 2020.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc.
